The bar for clinical research in surgical subspecialties has been rising over the past 10 yr. It is now essential that neurosurgeons are familiar with the principles of evidence-based medicine to evaluate and conduct sound clinical research. In this review, we highlight the importance of formulating a good research question, which serves as the foundation for meaningful investigation.
S
tandards and methods for clinical research in surgery have become more accepted and expected in the last 10 yr than they were in the past. 1 Although neurosurgery has been responsible for some randomized, surgical trials with clearly defined outcome measures and clear clinical questions, [2] [3] [4] [5] [6] the surgical case series is still the most common clinical research method in the surgical literature. Fortunately, training in clinical research methods is now integrated into most residency training programs.
Since the enactment of the Affordable Care Act in 2010, healthcare payers and providers have shifted focus towards improving the quality of healthcare delivery. Surgeons strive to practice "evidence-based" medicine and decision-making, which look to clinical trials and clinical research for guidance. 1 With this in mind, it is the responsibility of the academic neurosurgery community to ask clinically relevant and important questions and attempt to answer them with sound study design with objective reporting of results.
One of the most fundamental aspects of performing impactful clinical research is formulating a sound, relevant research question. The development of the research question should set the investigator on a clear research pathway and will help generate evidence that has meaning for patients and surgeons. The current proliferation of large databases combined with easy access to statistical software has allowed anyone to "look around" the data and see what comes up. Without a clear study question, these quests ABBREVIATIONS: MCID, minimal clinically important difference are often pointless or lead to findings that can be unclear or misleading. In this review, we highlight the importance of a well-designed study question and offer advice for writing one.
KEY CONCEPTS
Writing a clear primary question involves a series of steps to define all of the necessary details ( Figure) . The first step in writing a study question is to identify (precisely) the knowledge gap. This requires an intimate knowledge of the topic and the relevant literature. 7 A good study question should address an important gap in current knowledge, 8 and patients should be better off if that gap is filled. Haynes 7 suggests that delineating between current knowledge and ignorance is essential in formulating a sound study question.
A thorough assessment of the current state of knowledge can be done through a systematic review of the literature, interviews with focus groups and patients, and consultation with experts in the field of interest. Some granting institutions encourage applicants to perform a systematic review and conduct smaller pilot studies prior to applying for full clinical trial funding to ensure the fidelity of the research question. 1 In basic science and translational research, an exploratory analysis may be necessary prior to asking a specific study question. The formulation of an important research question requires understanding the biology, physiology, and epidemiology of the problem. 7 Current frustrations with the clinical management and/or clinical outcomes are often the driving force behind the question.
FIGURE. Flow diagram illustrating the necessary steps in determining and asking a good clinical research question.
Ideally, a research plan should have ONE primary study question that includes the patients to be studied, the treatment given, the outcome to be assessed, and the plans for analysis. It should be written so that a simple "yes or no" conclusion can be stated at the end of the study. The primary question sets the investigator in the right direction and usually determines sample size, feasibility, and budget. In addition, it is usually scrutinized in the grant review and publication process. Additional "secondary" questions may be planned, but they should never compromise the primary question. 1 Secondary questions might look at subgroups of the study sample or evaluate less important secondary outcomes. Their purpose is to identify potential explanations for the primary study result and to generate new study questions, but usually the study will not be powered to answer them definitively. The study power should be adequate to answer the one primary study question.
The development of a precise, answerable study question is a key early step in clinical research. Delving through large databases with statistical programs to find something "significant" without a predefined question or hypothesis only serves to "muddy" the waters and does not provide meaningful substance to the body of available literature. With the abundance of data available, the importance of a single, simple primary research question to answer is more important than ever. 8 Once a study question has been drafted, it should be widely circulated to coinvestigators, colleagues, and, if possible, patient representatives to assess whether it is clearly written, understandable, important, and answerable. Identifying an answerable question can be difficult for clinicians. We tend to want to answer too many questions at once. It is important to narrow the topic sufficiently to answer a single clear question. It may become apparent that there are multiple relevant questions to address for the clinical problem in question. The most important one with the greatest impact should be chosen if possible, although preliminary study questions that justify or help refine the main question may be necessary. In clinical research, the research question often stems from clinical scenarios that showcase a knowledge gap. It is important that asking a relevant research question and formulating and executing a study subsequently leads to translation of the results back to the clinical setting, which is the reason for formulating the research question in the first place.
Although a well-constructed research question can provide significant value when posed appropriately using the abovementioned criteria, a poorly planned research question may heavily influence the study design and lead to significant limitations when analyzing the data. This undercuts the ability of the study to clearly answer the question. Adequate time should be given to formulating the research question. Although often overlooked, the use of appropriate thought, resources, and investigation during this stage is crucial. Spending an hour with a statistician or clinical epidemiologist to write a focused study question is time well spent.
Published Criteria for Developing Research Questions
Hulley and colleagues 9 have described the FINER criteria (Table) as a roadmap in developing a good research question. The FINER criteria assess whether the study is feasible (F), addresses an interesting topic (I), involves novel ideas (N), can be ethically studied and would be amenable to institutional review board approval (E), and is relevant to the scientific community (R). The FINER criteria serve as a starting point to help investigators choose a research topic, but do place value on novel ideas. Although novelty is very important, there is also a role for studies that are not novel and are designed to reproduce the findings of other researchers. Another approach, the PICOT format, may be more helpful for defining the specific components of the research question. 8, 10, 11 The PICOT format defines the population (P), the proposed therapeutic intervention (I), the comparison group or cohort (C), the outcome of interest (O), and timing of the study or investigation (T). 8, 10, 11 Using this method can help frame the study around the question being asked by defining the inclusion and exclusion criteria of the larger clinical population. Once the population, intervention, and outcome are identified, the study designer may determine the most appropriate assessment tool.
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A Study Question for Assessment of a Therapeutic Intervention
Studies on therapeutic interventions should ideally provide high-quality data for making recommendations to patients. In these situations, we are usually faced with a decision to recommend the best of 2 or more treatment options. The research will likely be based on a general idea, such as, "Are adjustable shunt valves better than fixed valves for patients with hydrocephalus?" Based on this idea, a succinct study question should be written that will lead to a Yes/No answer. As noted above, the components of the question should include: who will be studied, what are the interventions, what is the outcome, and how the results will be analyzed. Therefore, the general study question above could be formulated more precisely as the following question: In children aged birth to 18 yr with newly diagnosed hydrocephalus, do adjustable shunt valves improve the 1-yr shunt survival from 60% (the predicted value for differential pressure valves) to 70%? Written in this way, the reader immediately understands who is going to be studied: children aged birth to 18 yr with newly diagnosed hydrocephalus will be included. The intervention is shunt insertion with an adjustable valve or a differential pressure valve. The primary outcome is shunt survival, implying a time-to-failure analysis. The improvement in shunt survival from 60% to 70% at 1 yr indicates the difference that the investigators would like to detect. The components of the question highlight the key aspects of the study proposal. These will be expanded in the detailed study protocol, but immediately upon reading the question, the reviewer understands the basic entry criteria, intervention, outcome, and analysis plans. The event rates in the question allow a sample size calculation that determines the study budget and feasibility.
The selection of a study sample has implications for internal and external validity of the project. External validity in the example stated above would be limited to children. The conclusions of this study question may not apply to elderly patients with normal pressure hydrocephalus. The effect of the sample selection on internal validity may be less obvious but relates to whether differences within the study population might affect the results. For example, it is possible that the study question above is too broad because it includes all forms of hydrocephalus. Perhaps adjustable valves are an advantage in older children with very large ventricles but they are not an advantage in infants with hydrocephalus. Inclusion of all ages therefore could result in a negative study and miss the positive effect in a subset of the study patients. The existing literature should be used to assess these issues and to further refine the study question if necessary. It may be appropriate to have a secondary question that asks whether adjustable valves improve shunt survival among the subgroup of older children with very large ventricles.
The choice of study intervention is important. For the results of the study to be useful, ideally the intervention should be available to practitioners. If the intervention is not widely available, however, the study results can also be used to justify expanded availability through policy change and training. In our example, it is unclear whether adjustable valves would be available to practitioners in some parts of the world. In addition, the intervention should be something that can be achieved by most surgeons. For example, if tumor removal is being studied and gross total resection is found to be important, then the study results only apply to surgeons who can achieve gross total resection.
Selection of the outcome measure is crucial. Ideally, only 1 measure should be chosen, and it should be the basis for the primary analysis. The primary outcome should be reliable and valid. A reliable measure provides a repeatable result if measured more than once. A valid measure accurately represents the finding of interest. If a measure is not reliable, it cannot be valid. Demonstrating reliability and validity require a lot of work, so investigators should look in the existing literature for outcome measures whose reliability and validity have already been demonstrated.
An outcome measure should be important to patients. Surrogate outcome measures may be considered when there is an extremely long time to a patient-centered outcome, but whenever possible, the study question should address outcomes that are patient focused. In our example above, shunt survival is likely to be important to patients since it results in hospital admission and repeat surgery. On the other hand, there is some evidence that patients will accept repeated procedures for hydrocephalus in order to achieve better cognitive function. In that case, a better outcome measure might be cognitive function at a specific age. In addition to being important to patients, the outcome should be measurable. Time to shunt failure is certainly measurable, and cognitive function in children can be assessed with the Bayley Scales of Infant and Toddler Development. 13 The use of a measurable outcome will enhance the reproducibility of the study results.
Finally, the selection of the primary outcome should consider observer bias. This is the phenomenon in which outcome assessment is influenced by the prior knowledge or bias of the assessor because of their awareness of the intervention. At first glance, shunt failure may appear to be quite objective. In fact, children can present with subtle symptoms and equivocal imaging so that a decision to revise the shunt can be difficult. In that situation, a surgeon assessing his own patient may choose to reoperate based on his or her knowledge of the valve in place. That is observer bias. To minimize observer bias, blinding is often used in clinical trials, but blinding is difficult to do in surgical interventions. In hydrocephalus clinical research, we have used an adjudication process 14 in which clinical records and imaging are presented to an adjudication committee after information about the intervention has been removed. The committee reviews the blinded data and determines, for each patient, whether they meet the definition of the primary outcome.
The study question should specify the magnitude of the difference in the outcome that investigators want to detect. The smaller the difference chosen, the larger the sample size that will be needed for the study. Ideally, investigators should choose the smallest difference that is clinically important. This is often referred to as the Minimal Clinically Important Difference (MCID). The MCID has been published for spine measures, 15 and this type of metric can be very useful in determining research questions. To determine MCID, input is required from patients and physicians. From the physician's perspective, the MCID is the smallest difference that would make the physician change his or her practice. It therefore incorporates complications and cost. Ideally, the MCID should also include patient input by assessing how much potential benefit a patient needs/expects to accept the risks, cost, pain, and inconvenience of the intervention. For most clinical outcomes, the MCID has not been formally determined, but the magnitude of difference that a study will be able to detect is very important and should be discussed and planned from the beginning.
A Study Question for Assessment of Association
Although study questions on therapeutic interventions help us the most, they are not always feasible. Other research designs may be necessary. One of the most common designs in surgical literature is the study of association. For example, an investigator may ask "What are the risk factors for recurrence after astrocytoma resection?" The same general principles for writing the study question should apply, but there are slight differences. Here, the study question should include the exposure of interest, the primary outcome, and the covariates that might impact the primary outcome, or the likelihood of receiving the intervention. This may result in the question being stated as follows: "When controlling for extent of resection, histology, and age, is BRAF status associated with tumor recurrence?" By writing the question in this way, the investigator demonstrates a priori knowledge of risk factors for recurrence and plans to account for them in the assessment of BRAF status. The question might be further improved by adding a definition of tumor recurrence and by specifying a time-dependent analysis plan.
CONCLUSION
Writing a clear primary question that specifies the key components of the research plan is an essential initial step in all clinical research projects. The main advantage is that it makes the investigator think about, and write down, the key factors that will define the study: who is being studied, what are they being exposed to (treatments or risk factors), and how are you going to measure the outcome? Getting these things right from the beginning requires identification of a specific gap in our knowledge, discussion and collaboration with colleagues, and consultation with experienced clinical researchers and statisticians. A well-written question will be the blueprint for a successful investigation and will be a reference point as the study protocol is developed in more detail.
Disclosure
COMMENT T
his article is of great value to anyone who reads the neurosurgical literature. It is not necessary to be planning a research study to benefit from the advice presented here. When considering whether or not to spend the time to read an article, the reader who understands what makes for a good research question will first determine if the authors have clearly presented a good research question as the foundation of their article. If they have not, the reader can move on, confident that nothing of great importance will be missed by consigning that article to the circular file.
The authors give sound advice for what should be the first step in beginning any research project: writing a clear, complete and concise research question. As they point out, good questions help define the data to be collected, the analytic techniques to be used, and the sample size, and guide the rest of the study design. Shared with colleagues, a good question can lead to advice on improving the research plan, finding existing publications on the topic that may have been missed or even learning that another research team has already embarked on a similar project. All of this can save time, resources, avoid embarrassment, and lead to better research outcomes.
The types of question asked differ depending on the circumstance. One may need to know how best to assess a patient, which requires evaluations of validity and reproducibility. The usefulness of a diagnostic test or procedure requires a comparison to a gold standard. The prognosis of a condition with or without treatment depends on objective observation of outcomes over time. Therapeutic efficacy questions revolve around unbiased comparisons of outcome. Questions of safety or harm assess the dependence of outcome on various factors. Choosing the right patient population, outcome measures, and type of analysis is a critical part of formulating a good research question.
Poorly conceived research questions can lead to confusing and inconclusive results. For example, composite outcomes, if not very carefully constructed, may defy clinical interpretation and, regardless of the quality of the conduct and analysis of the study, leave the reader confused as to the meaning of a "statistically significant" result. For example, the Management of Myelomeningocele Study (MOMS) had two predetermined composite outcomes. The first, "the rate of fetal or neonatal death or the need for a cerebrospinal fluid shunt" at 12 months of age is difficult to interpret. The apparent research question is "Do children with myeomeningocele diagnosed before birth have a lower rate of death or needing a CSF shunt within 12 months of birth if their myelomeningocele is repaired before or after birth?" 1 The forced equivalence of death or meeting the criteria for shunt placement does not make clinical sense. Clearly the impact on subsequent function and quality of life of being dead is different from that for having a CSF shunt. When contemplating the possible variations in the primary outcome results, irresolvable potential conflicts arise. The actual result of 68% of the prenatal group and 98% of the postnatal group meeting criteria for the primary outcome could, at the extremes, result from 68% of the prenatal group dying and 98% of the postnatal group requiring a shunt. It would be difficult for most people to accept this as a result favoring the prenatal group. A primary outcome measure that leads to confusing and controversial interpretations leads to a confusing and controversial study.
Therefore, both practitioners and researchers of neurosurgery are well advised to have a good understanding of what constitutes a good research question and to use that knowledge to advance their understanding of neurosurgical practice. The authors have provided an excellent guide to this topic.
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